medRxiv

Showing 3681 to 3690 of 4116 articles

Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study

medRxiv Jan 1, 2025
We aimed to conduct a comprehensive genomic analysis of ceftolozane/tazobactam (C/T) resistance mechanisms in Pseudomonas aeruginosa by combining novel institutional data with publicly available sequencing data. We analysed 1,682 P. aeruginosa isolat...
View on medRxiv DOI

Development and Validation of VC-MAES and VC-SEPS: Deep Learning-Based Early Warning Systems for Hospitalized Patients

medRxiv Jan 1, 2025
The timely detection of ward deterioration—including unplanned intensive care unit (ICU) transfer, cardiac arrest, death, and sepsis—remains an unmet need. Although rule-based early warning scores and newer machine-learning models have been introduce...
View on medRxiv DOI

Artificial Intelligence (AI)-Powered H&E Whole-Slide Image Analysis of Tertiary Lymphoid Structure (TLS) Independently Predicts Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Immunotherapy

medRxiv Jan 1, 2025
Tertiary lymphoid structures (TLSs) within the tumor microenvironment have emerged as potential indicators of treatment response to immune checkpoint inhibitors (ICIs). This study aims to explore the association between artificial intelligence (AI)-p...
View on medRxiv DOI

Evaluating General-Purpose LLMs for Patient-Facing Use: Dermatology-Centered Systematic Review and Meta-Analysis

medRxiv Jan 1, 2025
General-purpose large language models (LLMs) have rapidly evolved from experimental tools into widely adopted components of healthcare. Their proliferation – accelerated by the “ChatGPT effect” – has sparked intense interest across patient-facing spe...
View on medRxiv DOI

Antisense oligonucleotide depletion of CCDC146 is a broad-spectrum therapeutic strategy for ALS

medRxiv Jan 1, 2025
Amyotrophic lateral sclerosis (ALS) is a heritable and incurable disease defined by the degeneration of motor neurons (MNs), yet the genetics of ALS remain partially understood. Using a genomic deep learning-powered whole-genome analysis of 6,715 ALS...
View on medRxiv DOI

Sleep as a Modifiable Risk Factor for Childhood Autism: Stratified Analysis of U.S. National Survey of Children’s Health Data

medRxiv Jan 1, 2025
This study aimed to examine the association between age-specific sleep sufficiency and autism spectrum disorders (ASD) among U.S. children aged 6–17 years. Data were gathered from the 2022-2023 National Survey of Children’s Health (NSCH), including 6...
View on medRxiv DOI

AI vs Human Performance in Conversational Hospital-Based Neurological Diagnosis

medRxiv Jan 1, 2025
Most evaluations of artificial intelligence (AI) in medicine rely on static, multiple-choice benchmarks that fail to capture the dynamic, sequential nature of clinical diagnosis. While conversational AI has shown promise in telemedicine, these system...
View on medRxiv DOI

Automated and interoperable methods for generalizable development of clinical machine-learning models for predicting neuromorbidity in critically ill children

medRxiv Jan 1, 2025
To streamline the development of clinical machine learning (ML) models for predicting acute neurological morbidity in critically ill children by extending our prior work to create a standardized, reproducible, and scalable workflow leveraging Fast He...
View on medRxiv DOI

Light Convolutional Neural Network to Detect Chronic Obstructive Pulmonary Disease (COPDxNet): A Multicenter Model Development and External Validation Study

medRxiv Jan 1, 2025
Approximately 70% of adults with chronic obstructive pulmonary disease (COPD) remain undiagnosed. Opportunistic screening using chest computed tomography (CT) scans, commonly acquired in clinical practice, may be used to improve COPD detection throug...
View on medRxiv DOI

Personalized, closed-loop deep brain stimulation for chronic pain

medRxiv Jan 1, 2025
Chronic pain is a major healthcare problem associated with maladaptive brain circuit changes - many patients are unresponsive to all available therapies. Deep brain stimulation (DBS) is a promising treatment, but traditional targets have not proven c...
View on medRxiv DOI
Popular Topics
Popular Journals